1. Antipsychotic and anxiolytic properties of risperidone, haloperidol and methotrimeprazine in schizophrenic patients;Blin;Journal of Clinical Psychopharmacology,1996
2. Tatossian A Comparitive double-blind trial of the efficacy of risperidone, haloperidol and levomepromazine (methotrimeprazine) in patients with an acute exacerbation of schizophhrenia presenting psychotic anxiety symptoms Clinical research report (RIS-FRA-9003) 1991(unpublished data from Janssen)
3. Borison R Risperidone versus haloperidol versus placebo in the treatment of schizophrenia Clinical research report (RIS-USA-9001) 1991(unpublished data from Janssen)
4. Risperidone: clinical safety and efficacy in schizophrenia;Borison;Psychopharmacology Bulletin,1992
5. Bouchard RH Demers MF Merette C Pourcher E Classical neuroleptics (CNLP) vs risperdone (RIS) interim 12 months efficacy of a long-term, naturalistic study in schizophrenics 11th CINP Congress, Glasgow, Scotland